Page last updated: 2024-09-03

troxacitabine and Invasiveness, Neoplasm

troxacitabine has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, SD; Donehower, RC; Hidalgo, M; Jimeno, A; Laheru, D; Lee, CK; Ma, WW; Messersmith, WA	1

Trials

1 trial(s) available for troxacitabine and Invasiveness, Neoplasm

Article	Year
Phase I study of troxacitabine administered by continuous infusion in subjects with advanced solid malignancies. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:2 Topics: Adult; Aged; Cytosine; Dioxolanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Feasibility Studies; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms; Predictive Value of Tests; Probability; Risk Assessment; Survival Analysis; Time Factors; Treatment Outcome	2008

Article

Year

Phase I study of troxacitabine administered by continuous infusion in subjects with advanced solid malignancies.

Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:2

Topics: Adult; Aged; Cytosine; Dioxolanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Feasibility Studies; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms; Predictive Value of Tests; Probability; Risk Assessment; Survival Analysis; Time Factors; Treatment Outcome

2008